[REPLAY] Role and Benefits of Cytogenetics in the Management of Malignant Hemopathies

About us
Cerba is a leading reference in specialised medical biology in France and internationally. For over 50 years, it has been leveraging its medical expertise and strong capacity for innovation to serve patients, healthcare professionals, and the pharmaceutical industry.
Our expertise
Since 1967, Cerba has been leveraging its expertise and innovation to serve healthcare. Recognized in France and internationally, our laboratory is a leading player in specialised medical biology, offering a high level of excellence for patients and healthcare professionals.
Training and resources
We are committed daily to placing medical biology at the heart of the care pathway to improve patient management in terms of prevention, diagnosis, and monitoring of diseases. This involves medical and technical expertise, innovation, as well as a range of training programs and a constantly evolving array of services and tools.
Our news
Contact us

[REPLAY] Role and Benefits of Cytogenetics in the Management of Malignant Hemopathies

Cerba Live Session

This program is available in French with English subtitles.

12 December 2024

[REPLAY] Role and Benefits of Cytogenetics in the Management of Malignant Hemopathies

By Dr. Claire Bracquemart

Watch the replay >

For several years, we’ve been hearing that cytogenetics is headed for a bleak future, yet the demand has never been stronger than today...

Together, let’s take a look at this field within the management of malignant hemopathies.

Watch the replay to explore the role of oncological cytogenetics with clear and practical examples. We will also delve into key practical aspects, including the challenges of the pre-analytical phase, and guide you in interpreting the results together.